Laurent Chardonnet

Insider Reports History

Entity
Individual
Location
C/O Axcella Health Inc., 840 Memorial Drive, Cambridge, MA
Signature
/s/ Laurent Chardonnet
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurent Chardonnet:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prelude Therapeutics Inc Chief Financial Officer Common Stock 42.2K $159K $3.77 May 23, 2023 Direct
Prelude Therapeutics Inc Chief Financial Officer Employee Stock Option (right to buy) 150K Mar 1, 2024 Direct

Insider Reports Filed by Laurent Chardonnet

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRLD Prelude Therapeutics Inc Mar 1, 2024 1 $0 4 Mar 4, 2024 Chief Financial Officer
PRLD Prelude Therapeutics Inc May 23, 2023 1 $27.5K 4 May 25, 2023 Chief Financial Officer
PRLD Prelude Therapeutics Inc Feb 7, 2023 1 $0 4 Feb 9, 2023 Chief Financial Officer
PRLD Prelude Therapeutics Inc Dec 21, 2022 1 $0 4 Dec 22, 2022 Chief Financial Officer
PRLD Prelude Therapeutics Inc Dec 8, 2022 1 $47.6K 4 Dec 12, 2022 Chief Financial Officer
PRLD Prelude Therapeutics Inc Jun 1, 2022 1 $42.3K 4 Jun 1, 2022 Chief Financial Officer
PRLD Prelude Therapeutics Inc Mar 21, 2022 1 $48.8K 4 Mar 22, 2022 Chief Financial Officer
PRLD Prelude Therapeutics Inc Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Financial Officer
PRLD Prelude Therapeutics Inc Dec 13, 2021 1 $61.4K 4 Dec 14, 2021 Chief Financial Officer
PRLD Prelude Therapeutics Inc Nov 29, 2021 1 $0 4 Dec 1, 2021 Chief Financial Officer
PRLD Prelude Therapeutics Inc Nov 29, 2021 0 $0 3 Dec 1, 2021 Chief Financial Officer